HER2 status in recurrent/metastatic androgen receptor overexpressing salivary gland carcinoma patients

HER2 status in recurrent/metastatic androgen receptor overexpressing salivary gland carcinoma patients

BackgroundOverexpression of human epidermal growth factor receptor type 2 (HER2) occurs in almost 25-30% of androgen receptor (AR)-positive salivary gland carcinomas (SGCs), notably salivary duct carcinoma (SDC) and adenocarcinoma not otherwise specified (NOS). In the last years, several studies hav...

Full description

Bibliographic Details
Main Authors: Stefano Cavalieri, Imperia Nuzzolese, Arianna Ottini, Cristiana Bergamini, Carlo Resteghini, Elena Colombo, Salvatore Alfieri, Pasquale Quattrone, Giuseppina Calareso, Nicola Alessandro Iacovelli, Marzia Franceschini, Lisa Licitra
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-01-01
Series:Frontiers in Oncology
Subjects:
HER2
androgen receptor
SDC
salivary duct carcinoma
SGC
salivary gland carcinoma
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2022.1096068/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2022.1096068/full

Similar Items